Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies into Clinical Development

Endpoints News

Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle

Globe Newswire

Outpace Bio expands Seattle presence with cell therapy research hub & collaborations with leading experts in protein design & cancer immunotherapy

Globe Newswire

Outpace Bio to present new data on OutSmart™ IL-2/15, a CAR T cell-produced designed cytokine with tumor-localized immune cell activity, at the 2023 annual meeting of the American Society of Gene & Cell Therapy (ASGCT)

American Society for Gene & Cell Therapy (ASGCT)

OutSmart™ IL-2/15: A CAR T Cell-Produced Designed Cytokine with Tumor-Localized Immune Cell Activity

BioCentury

Keeping up with the protein designers

Globe Newswire

Outpace Bio, a leader in protein design for cell therapy, announces presentation at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Globe Newswire

Outpace Bio, a leader in protein design for cell therapy, strengthens executive leadership team with key appointments

Globe Newswire

Outpace Bio, a leader in protein design & cell engineering, adds Bahija Jallal to Board of Directors